vs
Embecta Corp.（EMBC）与OUTFRONT Media Inc.（OUT）财务数据对比。点击上方公司名可切换其他公司
OUTFRONT Media Inc.的季度营收约是Embecta Corp.的2.0倍（$513.3M vs $261.2M），OUTFRONT Media Inc.净利率更高（18.9% vs 16.9%，领先2.0%），OUTFRONT Media Inc.同比增速更快（4.1% vs -0.3%），OUTFRONT Media Inc.自由现金流更多（$93.3M vs $16.6M），过去两年OUTFRONT Media Inc.的营收复合增速更高（12.1% vs -4.6%）
Embecta Corp.是一家专注于糖尿病护理领域的全球医疗科技企业，主要设计、生产及销售胰岛素笔针、注射器、输注组件等给药装置，产品服务覆盖全球多个地区的患者、医疗机构及生物制药合作方。
OUTFRONT Media Inc.是一家美国广告企业，业务覆盖美国本土，由首席执行官Nick Brien领导美洲区业务，核心经营广告牌及公共交通展示广告两大业务板块，是户外广告领域的重要参与者。
EMBC vs OUT — 直观对比
营收规模更大
OUT
是对方的2.0倍
$261.2M
营收增速更快
OUT
高出4.3%
-0.3%
净利率更高
OUT
高出2.0%
16.9%
自由现金流更多
OUT
多$76.7M
$16.6M
两年增速更快
OUT
近两年复合增速
-4.6%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $261.2M | $513.3M |
| 净利润 | $44.1M | $96.8M |
| 毛利率 | 61.9% | — |
| 营业利润率 | 31.9% | 26.0% |
| 净利率 | 16.9% | 18.9% |
| 营收同比 | -0.3% | 4.1% |
| 净利润同比 | — | 30.8% |
| 每股收益（稀释后） | $0.74 | $0.57 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收EMBCOUT
| Q4 25 | $261.2M | $513.3M | ||
| Q3 25 | $264.0M | $467.5M | ||
| Q2 25 | $295.5M | $460.2M | ||
| Q1 25 | $259.0M | $390.7M | ||
| Q4 24 | $261.9M | $493.2M | ||
| Q3 24 | $286.1M | $451.9M | ||
| Q2 24 | $272.5M | $477.3M | ||
| Q1 24 | $287.2M | $408.5M |
净利润EMBCOUT
| Q4 25 | $44.1M | $96.8M | ||
| Q3 25 | $26.4M | $51.3M | ||
| Q2 25 | $45.5M | $19.5M | ||
| Q1 25 | $23.5M | $-20.6M | ||
| Q4 24 | $0 | $74.0M | ||
| Q3 24 | $14.6M | $34.6M | ||
| Q2 24 | $14.7M | $176.8M | ||
| Q1 24 | $28.9M | $-27.2M |
毛利率EMBCOUT
| Q4 25 | 61.9% | — | ||
| Q3 25 | 60.0% | — | ||
| Q2 25 | 66.7% | — | ||
| Q1 25 | 63.4% | — | ||
| Q4 24 | 60.0% | — | ||
| Q3 24 | 60.7% | — | ||
| Q2 24 | 69.8% | — | ||
| Q1 24 | 64.6% | — |
营业利润率EMBCOUT
| Q4 25 | 31.9% | 26.0% | ||
| Q3 25 | 21.4% | 19.2% | ||
| Q2 25 | 31.8% | 12.2% | ||
| Q1 25 | 24.3% | 3.6% | ||
| Q4 24 | 11.0% | 22.5% | ||
| Q3 24 | 9.2% | 15.8% | ||
| Q2 24 | 20.5% | 48.0% | ||
| Q1 24 | 13.6% | 3.4% |
净利率EMBCOUT
| Q4 25 | 16.9% | 18.9% | ||
| Q3 25 | 10.0% | 11.0% | ||
| Q2 25 | 15.4% | 4.2% | ||
| Q1 25 | 9.1% | -5.3% | ||
| Q4 24 | — | 15.0% | ||
| Q3 24 | 5.1% | 7.7% | ||
| Q2 24 | 5.4% | 37.0% | ||
| Q1 24 | 10.1% | -6.7% |
每股收益（稀释后）EMBCOUT
| Q4 25 | $0.74 | $0.57 | ||
| Q3 25 | $0.44 | $0.29 | ||
| Q2 25 | $0.78 | $0.10 | ||
| Q1 25 | $0.40 | $-0.14 | ||
| Q4 24 | $0.00 | $0.49 | ||
| Q3 24 | $0.24 | $0.19 | ||
| Q2 24 | $0.25 | $1.01 | ||
| Q1 24 | $0.50 | $-0.18 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $201.3M | $99.9M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $-613.1M | $710.4M |
| 总资产 | $1.1B | $5.3B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资EMBCOUT
| Q4 25 | $201.3M | $99.9M | ||
| Q3 25 | $225.5M | $63.0M | ||
| Q2 25 | $230.6M | $28.5M | ||
| Q1 25 | $209.3M | $30.5M | ||
| Q4 24 | $210.0M | $46.9M | ||
| Q3 24 | $267.5M | $28.0M | ||
| Q2 24 | $275.1M | $49.6M | ||
| Q1 24 | $299.8M | $42.4M |
总债务EMBCOUT
| Q4 25 | — | — | ||
| Q3 25 | $1.4B | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $1.6B | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益EMBCOUT
| Q4 25 | $-613.1M | $710.4M | ||
| Q3 25 | $-650.6M | $542.6M | ||
| Q2 25 | $-669.6M | $539.1M | ||
| Q1 25 | $-736.2M | $566.9M | ||
| Q4 24 | $-768.8M | $649.0M | ||
| Q3 24 | $-738.3M | $618.2M | ||
| Q2 24 | $-763.7M | $664.9M | ||
| Q1 24 | $-769.6M | $524.2M |
总资产EMBCOUT
| Q4 25 | $1.1B | $5.3B | ||
| Q3 25 | $1.1B | $5.2B | ||
| Q2 25 | $1.2B | $5.1B | ||
| Q1 25 | $1.1B | $5.1B | ||
| Q4 24 | $1.1B | $5.2B | ||
| Q3 24 | $1.3B | $5.2B | ||
| Q2 24 | $1.3B | $5.3B | ||
| Q1 24 | $1.2B | $5.5B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $17.2M | $118.1M |
| 自由现金流经营现金流 - 资本支出 | $16.6M | $93.3M |
| 自由现金流率自由现金流/营收 | 6.4% | 18.2% |
| 资本支出强度资本支出/营收 | 0.2% | 4.8% |
| 现金转化率经营现金流/净利润 | 0.39× | 1.22× |
| 过去12个月自由现金流最近4个季度 | $205.8M | $218.8M |
8季度趋势，按日历期对齐
经营现金流EMBCOUT
| Q4 25 | $17.2M | $118.1M | ||
| Q3 25 | $84.0M | $88.8M | ||
| Q2 25 | $81.2M | $67.1M | ||
| Q1 25 | $31.8M | $33.6M | ||
| Q4 24 | $-5.3M | $124.5M | ||
| Q3 24 | $26.6M | $73.1M | ||
| Q2 24 | $-2.1M | $71.0M | ||
| Q1 24 | $24.3M | $30.6M |
自由现金流EMBCOUT
| Q4 25 | $16.6M | $93.3M | ||
| Q3 25 | $76.7M | $67.7M | ||
| Q2 25 | $80.8M | $41.4M | ||
| Q1 25 | $31.7M | $16.4M | ||
| Q4 24 | $-6.8M | $106.3M | ||
| Q3 24 | — | $55.5M | ||
| Q2 24 | $-11.8M | $47.1M | ||
| Q1 24 | $20.9M | $12.2M |
自由现金流率EMBCOUT
| Q4 25 | 6.4% | 18.2% | ||
| Q3 25 | 29.1% | 14.5% | ||
| Q2 25 | 27.3% | 9.0% | ||
| Q1 25 | 12.2% | 4.2% | ||
| Q4 24 | -2.6% | 21.6% | ||
| Q3 24 | — | 12.3% | ||
| Q2 24 | -4.3% | 9.9% | ||
| Q1 24 | 7.3% | 3.0% |
资本支出强度EMBCOUT
| Q4 25 | 0.2% | 4.8% | ||
| Q3 25 | 2.8% | 4.5% | ||
| Q2 25 | 0.1% | 5.6% | ||
| Q1 25 | 0.0% | 4.4% | ||
| Q4 24 | 0.6% | 3.7% | ||
| Q3 24 | 0.0% | 3.9% | ||
| Q2 24 | 3.6% | 5.0% | ||
| Q1 24 | 1.2% | 4.5% |
现金转化率EMBCOUT
| Q4 25 | 0.39× | 1.22× | ||
| Q3 25 | 3.18× | 1.73× | ||
| Q2 25 | 1.78× | 3.44× | ||
| Q1 25 | 1.35× | — | ||
| Q4 24 | — | 1.68× | ||
| Q3 24 | 1.82× | 2.11× | ||
| Q2 24 | -0.14× | 0.40× | ||
| Q1 24 | 0.84× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
EMBC
| Pen Needles | $185.5M | 71% |
| Safety | $37.3M | 14% |
| Syringes | $30.7M | 12% |
| Manufacturing Facility | $4.1M | 2% |
OUT
| Static Displays | $236.3M | 46% |
| Other | $134.8M | 26% |
| Digital Displays | $125.3M | 24% |
| Other Revenues | $1.9M | 0% |
